Registration Dossier
Registration Dossier
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 618-804-0 | CAS number: 919-94-8
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data

Acute Toxicity: inhalation
Administrative data
- Endpoint:
- acute toxicity: inhalation
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- other: Modern GLP compliant guideline study, no restrictions
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 2 009
- Report date:
- 2009
Materials and methods
Test guideline
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 403 (Acute Inhalation Toxicity)
- GLP compliance:
- yes
- Test type:
- standard acute method
- Limit test:
- yes
Test material
- Reference substance name:
- 2-ethoxy-2-methylbutane
- EC Number:
- 618-804-0
- Cas Number:
- 919-94-8
- Molecular formula:
- C7H16O
- IUPAC Name:
- 2-ethoxy-2-methylbutane
- Details on test material:
- - Name of test material (as cited in study report): TAEE, tert-amyl ethyl ether, CAS No. 919-94-8
- Lot/batch No.: 00931302
- Description: colourless liquid
- Purity: 99.4%
- Date received: 22 October 2008
Constituent 1
Test animals
- Species:
- rat
- Strain:
- Wistar
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Source: Charles River UK, Margate, Kent, UK
- Age at study initiation: approx. 11-12 wk
- Weight at study initiation: males approx. 280 g, females approx. 210 g
- Fasting period before study: no
- Housing: group, 5/cage
- Diet (e.g. ad libitum): yes (except during exposure)
- Water (e.g. ad libitum): yes (except during exposure)
- Acclimation period: animals acclimated to holding tubes on study days -14, -13, -9, -8, -7 and -4
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 19-25
- Humidity (%): 40-70
- Air changes (per hr): at least 15
- Photoperiod (hrs dark / hrs light): 12/12
IN-LIFE DATES: From: 26 January 2009 To: 9 February 2009
Administration / exposure
- Route of administration:
- inhalation: vapour
- Type of inhalation exposure:
- nose only
- Vehicle:
- other: unchanged (no vehicle)
- Details on inhalation exposure:
- GENERATION OF TEST ATMOSPHERE / CHAMBER DESCRIPTION
- Exposure apparatus: ADG flow-through chamber
- Exposure chamber volume: 40 l
- Method of holding animals in test chamber: restraining tubes
- System of generating vapour: J-tube generator
- Airflow: 12 changes/hr
TEST ATMOSPHERE
- Analytical method used: GC-FID
- Samples taken from breathing zone: yes - Analytical verification of test atmosphere concentrations:
- yes
- Duration of exposure:
- 4 h
- Concentrations:
- Mean concentration over 4 hr = 23.2 mg/l
Concentration range over 4 hr = 21.9 to 25.8 mg/l - No. of animals per sex per dose:
- 5
- Control animals:
- no
- Details on study design:
- GENERAL
Male and female rats were exposed by nose-only inhalation for a single 4-hour inhalation exposure followed by an observation period of at least 14 days. The target concentration was 20 mg/l.
NOMINAL VAPOUR CONCENTRATION
The weight of the test article within the reservoir was recorded before and after the exposure and together with the volume of air passing through the chamber, and the nominal vapour concentration in the chamber calculated. This was found to be 34.0 mg/l.
ACHIEVED VAPOUR CONCENTRATION
Samples of chamber air were collected from the animals breathing zone at 30 min intervals into acetone (Dreschel tubes)and analysed by GC-FID (Varian CP-3380 with FID detection; J&W Scientific column with DB-1). The analytical procedures and method were subject to validation to international standards (Covance study 3042-007).
Results and discussion
Effect levels
- Sex:
- male/female
- Dose descriptor:
- LC50
- Effect level:
- > 23.2 mg/L air (analytical)
- Exp. duration:
- 4 h
- Remarks on result:
- other: One animal died during exposure; signs of mild CNS depression present in survivors
- Mortality:
- One male animal died suddenly in the first hour of exposure. No clinical signs preceded its death.
- Clinical signs:
- other: Treatment-related clinical signs included ataxia, bradypnoea, dyspnoea, hunched posture, prone and ptosis following exposure to the test article. One male exhibited decreased activity on Day 2. All animals appeared normal thereafter.
- Body weight:
- Both sexes exhibited a slight (approx. 3%) reduction in body weight during exposure and body weights remained depressed (at or just below pre-exposure values) to days 4-5. Weight gain thereafter appeared normal.
- Gross pathology:
- The decedent animal had red lungs, nasal cavity, adrenal, mandibular lymph node and dark thymus. The animal also had approximately 2 ml of red fluid in its thoracic cavity. Other animals had minor findings unrelated to treatment.
- Other findings:
- None
Applicant's summary and conclusion
- Interpretation of results:
- practically nontoxic
- Remarks:
- Migrated information Criteria used for interpretation of results: EU
- Conclusions:
- Not harmful by inhalation
- Executive summary:
Acute inhalation toxicity was determined in GLP compliant guideline study (OECD 403) using young adult Wistar rats of both sexes (age approx. 11-12 wk, bwt 210-280 g). Animals were exposed nose-only to a single vapour concentration of the test substance, and the achieved concentration confirmed using GC-FID. One male died during exposure, and the survivors exhibited signs of mild CNS depression with a slight (3%) reduction in body weight. There were no deaths during the 14 day follow-up period and no gross abnormalities detected in survivors at necropsy. The results demonstrate that the acute inhalation LC50 of tert-amyl ethyl ether is greater than 23.2 mg/l.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.

EU Privacy Disclaimer
This website uses cookies to ensure you get the best experience on our websites.